Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Neuro-Oncology
•
General Radiation Oncology
Do you include a dural CTV margin for intact brain metastases touching the dura when treating with SRS or fSRT?
Related Questions
Do you ever perform adaptive replanning for interfraction tumor volume changes appreciated during a fractionated SRS ( 5 fx) treatment for CNS metastases?
Is there a time interval after which you would not offer adjuvant radiotherapy for a malignant, grade 3 meningioma?
For those rare patients now out 5 years post GBM treatment and continuous Optune, is there a point one would stop Optune?
Would you offer adjuvant radiotherapy for a gross totally resected WHO grade 2 hemangiopericytoma/MFT of the brain in a patient with active multiple sclerosis?
How would you manage a very large diffuse skull base meningioma involving the olfactory groove, bilateral cavernous sinuses, and abutting optic chiasm that is not amenable to surgical resection?
How long after administration would you wait to proceed with an orthopedic surgery to a bone?
What constraint would you use for front eye/cornea when treating with palliative intent?
How do you proceed with radiation planning for preliminary suspected high grade gliomas after surgery when there is a delay in final molecular diagnosis?
How would you manage a Grade II IDH mutant astrocytoma with otherwise low risk features, but gemistocytic histology?
What dose and fractionation would you use for isolated intradural extramedullary drop metastases to the cervical and thoracic cord from solitary fibrous tumor/hemangiopericytoma?